IMCOOI
MRNA icon

Investment Management Corp of Ontario (IMCO)’s Moderna MRNA Stock Holding History

Investment Management Corp of Ontario (IMCO)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,268
Closed -$263K – 661
2025
Q1 		$263K Sell
9,268
-15,278
-62% -$542K 0.01% 627
2024
Q4 		$1.02M Buy
24,546
+13,678
+126% +$654K 0.03% 234
2024
Q3 		$726K Buy
10,868
+3,600
+50% +$331K 0.02% 451
2024
Q2 		$863K Buy
7,268
+2,000
+38% +$253K 0.02% 356
2024
Q1 		$561K Sell
5,268
-2,300
-30% -$232K 0.02% 398
2023
Q4 		$753K Buy
+7,568
New +$637K 0.02% 396

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return